Chemotherapy resistance research of lung cancer based on micro-fluidic chip system with flow medium

Biomedical Microdevices

Volumn 12, Issue 2, 2010, Pages 325-332

  Zhao, Long ^a   Wang, Zhenshan ^a   Fan, Sufang ^a   Meng, Qiang ^a   Li, Bowei ^a   Shao, Shujuan ^a   Wang, Qi ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Chemotherapy resistance; Lung cancer; Microfluidic system; SPCA1; VP 16

Indexed keywords

ANALYSIS TIME; ANTICANCER DRUG; APOPTOSIS; APOPTOTIC CELLS; CHIP SYSTEM; CONSTANT RATE; CONTROL FLOW RATE; FLOW CYTOMETRY ANALYSIS; IMMUNOFLUORESCENCE ASSAY; IN-VIVO; INTEGRATED MICROFLUIDIC SYSTEMS; LUNG CANCER; MICRO FLUIDIC SYSTEM; MICRO TOTAL ANALYSIS SYSTEMS; MICROENVIRONMENTS; NON SMALL CELL LUNG CANCER; REAGENT CONSUMPTION; SPACE REQUIREMENTS; VERAPAMIL;

ANIMAL CELL CULTURE; BIOLOGICAL ORGANS; CELL DEATH; CHEMOTHERAPY; FLOW CYTOMETRY; FLUIDIC DEVICES; FLUORESCENCE; MICROFLUIDICS; OXYGEN SUPPLY;

CELL CULTURE;

ETOPOSIDE; GLYCOPROTEIN P; VERAPAMIL;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; FLOW CYTOMETRY; FLOW RATE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; LUNG NON SMALL CELL CANCER; MICROELECTROMECHANICAL SYSTEM; MICROFLUIDICS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; CARCINOMA, BRONCHOGENIC; CARCINOMA, NON-SMALL-CELL LUNG; CELL CULTURE TECHNIQUES; CELL SURVIVAL; ETOPOSIDE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LUNG NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; P-GLYCOPROTEIN; PHYSICAL PROCESSES; RESEARCH;

EID: 77952889897     PISSN: 13872176     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10544-009-9388-3     Document Type: Article

References (18)

1. H Andersson A Van Den Berg 2003 Sens. Actuators 92 315 325 10.1016/S0925-4005(03)00266-1
2. XF Che Y Nakajima T Sumizawa R Ikeda XQ Ren CL Zheng M Mukai T Furukawa M Haraguchi H Gao Y Sugimoto S Akiyama 2002 Cancer Lett. 187 111 119 10.1016/S0304-3835(02)00359-2 (Pubitemid 35279339)
3. SH Choi SE Jin MK Lee SJ Lim JS Park BG Kim WS Ahn CK Kim 2008 Eur. J. Pharm. Biopharm. 68 545 554 10.1016/j.ejpb.2007.07.011 (Pubitemid 351318200)
4. SKW Dertinger DT Chiu NL Jeon GM Whitesides 2001 Anal. Chem. 73 1240 1246 10.1021/ac001132d (Pubitemid 32861911)
5. J El-Ali PK Sorger KF Jensen 2006 Nature 442 403 411 10.1038/nature05063 (Pubitemid 44264784)
6. SJ Froelich-Ammon N Osheroff 1995 J. Biol. Chem. 270 21429 21432 10.1074/jbc.270.37.21429
7. C Hrycyna 2001 Cell Dev. Biol. 12 247 256 10.1006/scdb.2000.0250
8. A Khademhosseini R Langer J Borenstein JP Vacanti 2006 Proc. Natl. Acad. Sci. 103 2480 2487 10.1073/pnas.0507681102
9. V Ponce de León R Barrera-Rodríguez 2005 Cancer Cell Int. 5 1 20 10.1186/1475-2867-5-20 (Pubitemid 41460746)
10. D Reyes D Iossifidis P Auroux A Manz 2002 Anal. Chem. 74 2623 2636 10.1021/ac0202435 (Pubitemid 34651165)
11. ZE Sauna MM Smith M Müller KM Kerr 2001 Ambudkar SV J. Bioenerg. Biomembr. 33 481 491 10.1023/A:1012875105006 (Pubitemid 34052574)
12. AW Tilles H Baskaran P Roy ML Yarmush M Toner 2001 Biotechnol. Bioeng. 73 379 389 10.1002/bit.1071 (Pubitemid 32493234)
13. A Tomida T Tsuruo 1999 Anticancer Drug Des. 14 169 177
14. YS Torisawa A Takagi Y Nashimoto T Yasukawa H Shiku T Matsue 2007 Biomaterials 28 559 566 10.1016/j.biomaterials.2006.08.054 (Pubitemid 44602232)
15. A Tudos G Besselink R Schasfoort 2001 Lab Chip 1 83 95 10.1039/b106958f
16. E Verpoorte 2002 Electrophoresis 23 677 712 10.1002/1522-2683(200203)23: 5<677::AID-ELPS677>3.0.CO;2-8 (Pubitemid 34262874)
17. Y Wang W Wang S Wang 2008 BMC Cancer 8 372 381 10.1186/1471-2407-8-372
18. CQ Yi CW Li SL Ji MS Yang 2006 Anal. Chim. Acta 560 1 23 10.1016/j.aca.2005.12.037 (Pubitemid 43286909)